University of Washington — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University of Washington appears in 608 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials608

Recruiting shown48

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung CancerNCT07322341 · lead sponsor · 2026-10-01

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO TrialNCT07698535 · lead sponsor · 2026-10-01

METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)NCT07699380 · lead sponsor · 2026-09-01

Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNCT07573241 · lead sponsor · 2026-07-17

Kulindana: Community-friendly Delivery and Monitoring of TPT to Improve Uptake and Reduce TB TransmissionNCT07628140 · lead sponsor · 2026-07-14

Hybrid Type-1 Effectiveness-Implementation Trial of Motivation Matters!NCT06745050 · lead sponsor · 2026-03-30

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast CancerNCT07078604 · lead sponsor · 2026-03-24

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast CancerNCT06502691 · lead sponsor · 2026-02-26

Integrating HIV Prevention With TB Household Contact Evaluation in UgandaNCT07119359 · lead sponsor · 2025-12-10

HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning ClinicsNCT07089966 · lead sponsor · 2025-12-01

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast CancerNCT07112053 · lead sponsor · 2025-11-17

Preliminary Efficacy of an mHealth Intervention in West AfricaNCT07276321 · lead sponsor · 2025-11-03

Scale-up of an Evidence-based Adolescent Transition Package to Support Transitional Care Among Youth Living With HIVNCT06924073 · lead sponsor · 2025-10-16

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIVNCT07105007 · lead sponsor · 2025-08-15

A Trial Testing a Two-way SMS Platform to Recognize and Prevent Wasting Among HIV-infected and HIV-exposed Uninfected Children in KenyaNCT06842732 · lead sponsor · 2025-06-05

The Impact of Vaginal Washing on Cervical InflammationNCT06615232 · lead sponsor · 2025-05-16

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing DiseaseNCT06526299 · lead sponsor · 2025-04-29

PAH Exercise StudyNCT06941441 · lead sponsor · 2025-04-15

Building Research for Intervention Development in Gliosis and Eating HabitsNCT06870578 · lead sponsor · 2025-04-03

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung CancerNCT06518057 · lead sponsor · 2025-03-03

Improving Perinatal Outcomes Among Kenyan Pregnant Women With an Integrated STI Testing ModelNCT06203951 · lead sponsor · 2025-01-27

Factorial Optimization Trial to Test Cognitive Behavioral Therapy Components for Multiple Sclerosis FatigueNCT06809192 · lead sponsor · 2025-01-10

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit SurvivorsNCT06411561 · lead sponsor · 2024-12-26

Action Towards Health Equity and Improved Air Quality in the Duwamish Valley: A Multilevel Asthma InterventionNCT06552013 · lead sponsor · 2024-07-30

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast CancerNCT06179303 · lead sponsor · 2024-07-22

The Airports, Air Quality, and Asthma (AAA) StudyNCT07047430 · lead sponsor · 2024-06-01

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA StudyNCT06039371 · lead sponsor · 2024-05-21

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 DiabetesNCT05822609 · lead sponsor · 2024-04-05

Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment ServicesNCT05404958 · lead sponsor · 2024-03-14

Repurposing Valsartan May Protect Against Pulmonary HypertensionNCT06053580 · lead sponsor · 2024-02-28

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIVNCT06126913 · lead sponsor · 2024-01-15

Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 DiabetesNCT05780905 · lead sponsor · 2024-01-11

One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care ProjectNCT05905640 · lead sponsor · 2024-01-01

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBINCT06005194 · lead sponsor · 2023-11-14

Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West AfricaNCT05703711 · lead sponsor · 2023-10-25

ADAPT Study: Assessing Diet, Appetite and Physiology Throughout Weight Loss Study)NCT06174389 · lead sponsor · 2023-10-01

Wakaya: Rising Up for Choctaw Youth HealthNCT05818384 · lead sponsor · 2023-04-28

SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung CancerNCT05570825 · lead sponsor · 2023-04-06

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung CancerNCT05242965 · lead sponsor · 2023-03-24

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast CancerNCT04329065 · lead sponsor · 2022-04-20

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate CancerNCT04489719 · lead sponsor · 2021-04-16

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC StudyNCT04175431 · lead sponsor · 2020-09-30

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL StudyNCT04472338 · lead sponsor · 2020-05-21

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung CancerNCT04151940 · lead sponsor · 2019-09-26

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD PatientsNCT02537769 · lead sponsor · 2015-08-01

The Parkinson's Genetic Research StudyNCT01558479 · lead sponsor · 2009-09-01

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial CancerNCT01050504 · lead sponsor · 2009-08-01

Prostate Active Surveillance StudyNCT00756665 · lead sponsor · 2008-07-01

Implementation Outcomes and Cost-effectiveness of Developmental Monitoring for Children Exposed to HIVNCT07457411 · lead sponsor · 2027-01-01

NOT_YET_RECRUITING

Pharmacies in HIV Prevention: Fellowship, Fundamentals, and Sustainable FinancesNCT07829250 · lead sponsor · 2026-11-01

NOT_YET_RECRUITING

Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern AfricaNCT07430826 · lead sponsor · 2026-11-01

NOT_YET_RECRUITING

Design and Pilot Implementation of a Chatbot to Support Breast Cancer Screening Among Black WomenNCT07858825 · lead sponsor · 2026-10-26

NOT_YET_RECRUITING

Inherited and Environmental Risks Acting on Body WeightNCT07430852 · lead sponsor · 2026-10-15

ENROLLING_BY_INVITATION

A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer BurdenNCT07721259 · lead sponsor · 2026-09-30

NOT_YET_RECRUITING

My MS Toolkit: An Internet-Based Depression Self-Management Program for Adults Living With Multiple SclerosisNCT07636434 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

Combating Age-related Failure of Myelination in Multiple Sclerosis: An Exploratory StudyNCT07723599 · lead sponsor · 2026-08-01

NOT_YET_RECRUITING

Home-based Spinal Cord Stimulation for Hand & Arm Function in MSNCT07673354 · lead sponsor · 2026-07-16

ENROLLING_BY_INVITATION

Dry Weight Reduction Intervention Via Extra UltrafiltrationNCT07637110 · lead sponsor · 2026-06-01

NOT_YET_RECRUITING

Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender WomenNCT07361926 · lead sponsor · 2026-05-01

NOT_YET_RECRUITING

Improving Health Among Disadvantaged Girls to Slow Pubertal Onset and Reduce Long-term Health RisksNCT07460544 · lead sponsor · 2026-05-01

NOT_YET_RECRUITING

Drugs studied in this sponsor's trials

113 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Washington as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo22

cyclophosphamide9

docetaxel9

paclitaxel9

letrozole8

carboplatin7

cisplatin7

valacyclovir7

placebo RxCUI 8375 · Lead sponsor in 15 linked trial(s) · 3 currently recruiting 22 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 9 linked trial(s) · 0 currently recruiting 9 trials docetaxel RxCUI 72962 · Lead sponsor in 9 linked trial(s) · 2 currently recruiting 9 trials paclitaxel RxCUI 56946 · Lead sponsor in 9 linked trial(s) · 1 currently recruiting 9 trials letrozole RxCUI 72965 · Lead sponsor in 8 linked trial(s) · 1 currently recruiting 8 trials carboplatin RxCUI 40048 · Lead sponsor in 7 linked trial(s) · 2 currently recruiting 7 trials cisplatin RxCUI 2555 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 7 trials valacyclovir RxCUI 73645 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 7 trials abiraterone acetate RxCUI 1100071 · Lead sponsor in 6 linked trial(s) · 1 currently recruiting 6 trials capecitabine RxCUI 194000 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 5 trials prednisone RxCUI 8640 · Lead sponsor in 5 linked trial(s) · 1 currently recruiting 5 trials acyclovir RxCUI 281 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials doxorubicin hydrochloride RxCUI 142433 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials etoposide RxCUI 4179 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials exemestane RxCUI 258494 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials leuprolide acetate RxCUI 203217 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials olaparib RxCUI 1597582 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials Truvada RxCUI 495430 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials vinorelbine RxCUI 39541 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials anastrozole RxCUI 84857 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials apalutamide RxCUI 1999574 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials fluoroestradiol F-18 RxCUI 2372221 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials goserelin RxCUI 50610 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials isoniazid RxCUI 6038 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials

Sponsor roles

lead sponsor454

collaborator154

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.